{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T13:26:43Z","timestamp":1785331603103,"version":"3.55.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1245\/s10434-025-18903-4","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T18:39:51Z","timestamp":1765910391000},"page":"2972-2984","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prophylactic Intraperitoneal Chemotherapy with Platinum Agents Following Curative Resection for Colorectal Cancer: A Systematic Review and Meta-Analysis"],"prefix":"10.1245","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0722-827X","authenticated-orcid":false,"given":"Ahmed Dawood","family":"Al Mahrizi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Mossolem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Major","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Elshafei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riddhi","family":"Machchhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,16]]},"reference":[{"issue":"8","key":"18903_CR1","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.3390\/cancers16081530","volume":"16","author":"G Roshandel","year":"2024","unstructured":"Roshandel G, Ghasemi-Kebria F, Malekzadeh R. Colorectal Cancer: Epidemiology, Risk Factors, and Prevention. Cancers. 2024;16(8):1530. https:\/\/doi.org\/10.3390\/cancers16081530.","journal-title":"Cancers."},{"key":"18903_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2025.102666","volume":"104","author":"J Zhou","year":"2025","unstructured":"Zhou J, Yang Q, Zhao S, et al. Evolving landscape of colorectal cancer: Global and regional burden, risk factor dynamics, and future scenarios (the Global Burden of Disease 1990\u20132050). Ageing Res Rev. 2025;104:102666. https:\/\/doi.org\/10.1016\/j.arr.2025.102666.","journal-title":"Ageing Res Rev."},{"issue":"2","key":"18903_CR3","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","volume":"72","author":"E Morgan","year":"2023","unstructured":"Morgan E, Arnold M, Gini A, et al. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023;72(2):338\u201344. https:\/\/doi.org\/10.1136\/gutjnl-2022-327736.","journal-title":"Gut."},{"issue":"3","key":"18903_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin."},{"issue":"21","key":"18903_CR5","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.1002\/cncr.32347","volume":"125","author":"J Virostko","year":"2019","unstructured":"Virostko J, Capasso A, Yankeelov TE, Goodgame B. Recent trends in age at diagnosis of colorectal cancer in the United States National Cancer Database, 2004\u20132015. Cancer. 2019;125(21):3828\u201335. https:\/\/doi.org\/10.1002\/cncr.32347.","journal-title":"Cancer."},{"issue":"19","key":"18903_CR6","doi-asserted-by":"publisher","first-page":"4799","DOI":"10.3390\/cancers14194799","volume":"14","author":"D Sifaki-Pistolla","year":"2022","unstructured":"Sifaki-Pistolla D, Poimenaki V, Fotopoulou I, et al. Significant Rise of Colorectal Cancer Incidence in Younger Adults and Strong Determinants: 30 Years Longitudinal Differences between under and over 50s. Cancers. 2022;14(19):4799. https:\/\/doi.org\/10.3390\/cancers14194799.","journal-title":"Cancers."},{"issue":"3_suppl","key":"18903_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1200\/JCO.2024.42.3_suppl.91","volume":"42","author":"Z Gottschalk","year":"2024","unstructured":"Gottschalk Z, Redman MW, Baker KK, et al. Comparison of the disease presentation of early- vs later-onset colorectal cancer within the prospective ColoCare study. J Clin Oncol. 2024;42(3_suppl):91\u201391. https:\/\/doi.org\/10.1200\/JCO.2024.42.3_suppl.91.","journal-title":"J Clin Oncol."},{"issue":"5","key":"18903_CR8","doi-asserted-by":"publisher","first-page":"e2413157","DOI":"10.1001\/jamanetworkopen.2024.13157","volume":"7","author":"J Demb","year":"2024","unstructured":"Demb J, Kolb JM, Dounel J, et al. Red Flag Signs and Symptoms for Patients With Early-Onset Colorectal Cancer: A Systematic Review and Meta-Analysis. JAMA Netw Open. 2024;7(5):e2413157. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.13157.","journal-title":"JAMA Netw Open."},{"issue":"6","key":"18903_CR9","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/bjc.2017.236","volume":"117","author":"ML T\u00f8rring","year":"2017","unstructured":"T\u00f8rring ML, Murchie P, Hamilton W, et al. Evidence of advanced stage colorectal cancer with longer diagnostic intervals: a pooled analysis of seven primary care cohorts comprising 11 720 patients in five countries. Br J Cancer. 2017;117(6):888\u201397. https:\/\/doi.org\/10.1038\/bjc.2017.236.","journal-title":"Br J Cancer."},{"key":"18903_CR10","doi-asserted-by":"publisher","unstructured":"US Preventive Services Task Force. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2021;325(19):1965-1977. https:\/\/doi.org\/10.1001\/jama.2021.6238","DOI":"10.1001\/jama.2021.6238"},{"issue":"16","key":"18903_CR11","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMra2200869","volume":"386","author":"FA Sinicrope","year":"2022","unstructured":"Sinicrope FA. Increasing Incidence of Early-Onset Colorectal Cancer. N Engl J Med. 2022;386(16):1547\u201358. https:\/\/doi.org\/10.1056\/NEJMra2200869.","journal-title":"N Engl J Med."},{"issue":"19","key":"18903_CR12","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1001\/jama.2021.5746","volume":"325","author":"AB Knudsen","year":"2021","unstructured":"Knudsen AB, Rutter CM, Peterse EFP, et al. Colorectal Cancer Screening: An Updated Modeling Study for the US Preventive Services Task Force. JAMA. 2021;325(19):1998\u20132011. https:\/\/doi.org\/10.1001\/jama.2021.5746.","journal-title":"JAMA."},{"issue":"3","key":"18903_CR13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3322\/caac.21772","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73(3):233\u201354. https:\/\/doi.org\/10.3322\/caac.21772.","journal-title":"CA Cancer J Clin."},{"issue":"10","key":"18903_CR14","doi-asserted-by":"publisher","first-page":"e2436358","DOI":"10.1001\/jamanetworkopen.2024.36358","volume":"7","author":"S Siddique","year":"2024","unstructured":"Siddique S, Wang R, Yasin F, et al. USPSTF Colorectal Cancer Screening Recommendation and Uptake for Individuals Aged 45 to 49 Years. JAMA Netw Open. 2024;7(10):e2436358. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.36358.","journal-title":"JAMA Netw Open."},{"key":"18903_CR15","unstructured":"MD RES. Therapy for Early-Stage Colorectal Cancer | CancerNetwork. September 22, 2025. Accessed September 21, 2025. https:\/\/www.cancernetwork.com\/view\/therapy-early-stage-colorectal-cancer"},{"issue":"12","key":"18903_CR16","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1046\/j.1365-2168.2002.02274.x","volume":"89","author":"DG Jayne","year":"2002","unstructured":"Jayne DG, Fook S, Loi C, Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer. Br J Surg. 2002;89(12):1545\u201350. https:\/\/doi.org\/10.1046\/j.1365-2168.2002.02274.x.","journal-title":"Br J Surg."},{"issue":"8","key":"18903_CR17","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1001\/jamaoncol.2021.0580","volume":"7","author":"RM van Stein","year":"2021","unstructured":"van Stein RM, Aalbers AGJ, Sonke GS, van Driel WJ. Hyperthermic Intraperitoneal Chemotherapy for Ovarian and Colorectal Cancer: A Review. JAMA Oncol. 2021;7(8):1231\u20138. https:\/\/doi.org\/10.1001\/jamaoncol.2021.0580.","journal-title":"JAMA Oncol."},{"issue":"2","key":"18903_CR18","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrclinonc.2009.217","volume":"7","author":"WP Ceelen","year":"2010","unstructured":"Ceelen WP, Flessner MF. Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence. Nat Rev Clin Oncol. 2010;7(2):108\u201316. https:\/\/doi.org\/10.1038\/nrclinonc.2009.217.","journal-title":"Nat Rev Clin Oncol."},{"issue":"7","key":"18903_CR19","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/jamasurg.2023.0662","volume":"158","author":"A Arjona-S\u00e1nchez","year":"2023","unstructured":"Arjona-S\u00e1nchez A, Espinosa-Redondo E, Guti\u00e9rrez-Calvo A, et al. Efficacy and Safety of Intraoperative Hyperthermic Intraperitoneal Chemotherapy for Locally Advanced Colon Cancer: A Phase 3 Randomized Clinical Trial. JAMA Surg. 2023;158(7):683\u201391. https:\/\/doi.org\/10.1001\/jamasurg.2023.0662.","journal-title":"JAMA Surg."},{"issue":"5","key":"18903_CR20","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1080\/02656736.2017.1401742","volume":"34","author":"PL Feingold","year":"2018","unstructured":"Feingold PL, Klemen ND, Kwong MLM, Hashimoto B, Rudloff U. Adjuvant intraperitoneal chemotherapy for the treatment of colorectal cancer at risk for peritoneal carcinomatosis: a systematic review. Int J Hyperth Off J Eur Soc Hyperthermic Oncol North Am Hyperth Group. 2018;34(5):501\u201311. https:\/\/doi.org\/10.1080\/02656736.2017.1401742.","journal-title":"Int J Hyperth Off J Eur Soc Hyperthermic Oncol North Am Hyperth Group."},{"issue":"2","key":"18903_CR21","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/DCR.0000000000002323","volume":"65","author":"JD Vogel","year":"2022","unstructured":"Vogel JD, Felder SI, Bhama AR, et al. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Colon Cancer. Dis Colon Rectum. 2022;65(2):148. https:\/\/doi.org\/10.1097\/DCR.0000000000002323.","journal-title":"Dis Colon Rectum."},{"issue":"2","key":"18903_CR22","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1200\/JCO.22.02644","volume":"42","author":"ES Zwanenburg","year":"2024","unstructured":"Zwanenburg ES, El Klaver C, Wisselink DD, et al. Adjuvant Hyperthermic Intraperitoneal Chemotherapy in Patients With Locally Advanced Colon Cancer (COLOPEC): 5-Year Results of a Randomized Multicenter Trial. J Clin Oncol Off J Am Soc Clin Oncol. 2024;42(2):140\u20135. https:\/\/doi.org\/10.1200\/JCO.22.02644.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol."},{"issue":"9","key":"18903_CR23","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S1470-2045(20)30322-3","volume":"21","author":"D Go\u00e9r\u00e9","year":"2020","unstructured":"Go\u00e9r\u00e9 D, Glehen O, Quenet F, et al. Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study. Lancet Oncol. 2020;21(9):1147\u201354. https:\/\/doi.org\/10.1016\/S1470-2045(20)30322-3.","journal-title":"Lancet Oncol."},{"issue":"6","key":"18903_CR24","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1002\/jso.27885","volume":"130","author":"S Kusamura","year":"2024","unstructured":"Kusamura S, Bhatt A, van Der Speeten K, et al. Review of 2022 PSOGI\/RENAPE Consensus on HIPEC. J Surg Oncol. 2024;130(6):1290\u20138. https:\/\/doi.org\/10.1002\/jso.27885.","journal-title":"J Surg Oncol."},{"issue":"20","key":"18903_CR25","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","volume":"21","author":"VJ Verwaal","year":"2003","unstructured":"Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21(20):3737\u201343. https:\/\/doi.org\/10.1200\/JCO.2003.04.187.","journal-title":"J Clin Oncol."},{"issue":"16","key":"18903_CR26","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1200\/JCO.2004.10.012","volume":"22","author":"O Glehen","year":"2004","unstructured":"Glehen O, Kwiatkowski F, Sugarbaker PH, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol. 2004;22(16):3284\u201392. https:\/\/doi.org\/10.1200\/JCO.2004.10.012.","journal-title":"J Clin Oncol."},{"key":"18903_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ."},{"key":"18903_CR28","unstructured":"PROSPERO. Accessed September 24, 2025. https:\/\/www.crd.york.ac.uk\/prospero\/"},{"key":"18903_CR29","unstructured":"Schwarzer G. meta: General Package for Meta-Analysis. Published online September 1, 2025. Accessed September 24, 2025. https:\/\/cran.r-project.org\/web\/packages\/meta\/index.html"},{"key":"18903_CR30","unstructured":"Wickham H, Fran\u00e7ois R, Henry L, et al. dplyr: A Grammar of Data Manipulation. Published online November 17, 2023. Accessed September 24, 2025. https:\/\/cran.r-project.org\/web\/packages\/dplyr\/index.html"},{"issue":"1","key":"18903_CR31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jrsm.1411","volume":"12","author":"LA McGuinness","year":"2021","unstructured":"McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods. 2021;12(1):55\u201361. https:\/\/doi.org\/10.1002\/jrsm.1411.","journal-title":"Res Synth Methods."},{"issue":"1","key":"18903_CR32","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12957-021-02197-3","volume":"19","author":"A Shang","year":"2021","unstructured":"Shang A, Wang S, Yang Y, et al. Effect and safety of intraoperative intraperitoneal chemotherapy on patients suffering from colorectal cancer. World J Surg Oncol. 2021;19(1):84. https:\/\/doi.org\/10.1186\/s12957-021-02197-3.","journal-title":"World J Surg Oncol."},{"issue":"1","key":"18903_CR33","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/s12916-025-04180-1","volume":"23","author":"H Su","year":"2025","unstructured":"Su H, Zhang R, Li Y, et al. Intraoperatively preventive intraperitoneal perfusion chemotherapy with lobaplatin in colorectal cancer: a prospective, randomised, controlled, multicentre study. BMC Med. 2025;23(1):336. https:\/\/doi.org\/10.1186\/s12916-025-04180-1.","journal-title":"BMC Med."},{"issue":"2","key":"18903_CR34","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","volume":"22","author":"F Qu\u00e9net","year":"2021","unstructured":"Qu\u00e9net F, Elias D, Roca L, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(2):256\u201366. https:\/\/doi.org\/10.1016\/S1470-2045(20)30599-4.","journal-title":"Lancet Oncol."},{"issue":"2","key":"18903_CR35","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.clcc.2024.12.001","volume":"24","author":"N Tinsley","year":"2025","unstructured":"Tinsley N, O\u2019Dwyer ST, Nagaraju R, et al. Oncological Outcomes From Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy for Colorectal Cancer Peritoneal Metastases. Clin Colorectal Cancer. 2025;24(2):166\u201379. https:\/\/doi.org\/10.1016\/j.clcc.2024.12.001.","journal-title":"Clin Colorectal Cancer."},{"issue":"3","key":"18903_CR36","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1245\/s10434-023-14608-8","volume":"31","author":"E Sarfaty","year":"2024","unstructured":"Sarfaty E, Khajoueinejad N, Yu AT, et al. Actual 5-Year Survival After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis of Colorectal Origin. Ann Surg Oncol. 2024;31(3):1970\u20139. https:\/\/doi.org\/10.1245\/s10434-023-14608-8.","journal-title":"Ann Surg Oncol."},{"key":"18903_CR37","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ejca.2015.09.017","volume":"53","author":"PH Cashin","year":"2016","unstructured":"Cashin PH, Mahteme H, Sp\u00e5ng N, et al. Cytoreductive surgery and intraperitoneal chemotherapy versus systemic chemotherapy for colorectal peritoneal metastases: A randomised trial. Eur J Cancer. 2016;53:155\u201362. https:\/\/doi.org\/10.1016\/j.ejca.2015.09.017.","journal-title":"Eur J Cancer."},{"issue":"1","key":"18903_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3978\/j.issn.2078-6891.2015.101","volume":"7","author":"KA Cummins","year":"2016","unstructured":"Cummins KA, Russell GB, Votanopoulos KI, Shen P, Stewart JH, Levine EA. Peritoneal dissemination from high-grade appendiceal cancer treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). J Gastrointest Oncol. 2016;7(1):3\u20139. https:\/\/doi.org\/10.3978\/j.issn.2078-6891.2015.101.","journal-title":"J Gastrointest Oncol."},{"issue":"6","key":"18903_CR39","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3390\/curroncol32060325","volume":"32","author":"K Jin","year":"2025","unstructured":"Jin K, Lin X, Xia X, et al. Incidence and Risk Factors of Platinum-Based Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Meta-Analysis. Curr Oncol. 2025;32(6):325. https:\/\/doi.org\/10.3390\/curroncol32060325.","journal-title":"Curr Oncol."},{"issue":"2","key":"18903_CR40","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10330-022-0603-3","volume":"9","author":"Q Li","year":"2023","unstructured":"Li Q, Li X, Feng L, Chen X, Xia D, Xu L. Preliminary security investigation and short-time follow-up of intraoperative intraperitoneal chemotherapy with lobaplatin for advanced colorectal cancer. Oncol Transl Med. 2023;9(2):93. https:\/\/doi.org\/10.1007\/s10330-022-0603-3.","journal-title":"Oncol Transl Med."},{"issue":"3","key":"18903_CR41","doi-asserted-by":"publisher","first-page":"526","DOI":"10.31925\/farmacia.2023.3.10","volume":"71","author":"C Xiang","year":"2023","unstructured":"Xiang C. Efficacy and safety of intraperitoneal infusion of raltitrexed in laparoscopic radical resection of rectal cancer. FARMACIA. 2023;71(3):526\u201332. https:\/\/doi.org\/10.31925\/farmacia.2023.3.10.","journal-title":"FARMACIA."},{"issue":"11","key":"18903_CR42","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.3390\/cancers12113478","volume":"12","author":"JJ Tuech","year":"2020","unstructured":"Tuech JJ, Pinson J, Nouhaud FX, et al. Total Pelvic Exenteration, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy for Rectal Cancer with Associate Peritoneal Metastases: Surgical Strategies to Optimize Safety. Cancers. 2020;12(11):3478. https:\/\/doi.org\/10.3390\/cancers12113478.","journal-title":"Cancers."},{"issue":"2","key":"18903_CR43","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.3390\/curroncol30020114","volume":"30","author":"X Guo","year":"2023","unstructured":"Guo X, Lin Y, Shen C, et al. Comparative Study of Short-Term Efficacy and Safety of Mitomycin versus Lobaplatin for Hyperthermic Intraperitoneal Chemotherapy after Radical Surgery in Colorectal Cancer with High-Risk Factors for Peritoneal Carcinomatosis: A Propensity Score Matching Analysis. Curr Oncol. 2023;30(2):1488\u2013501. https:\/\/doi.org\/10.3390\/curroncol30020114.","journal-title":"Curr Oncol."},{"issue":"11","key":"18903_CR44","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1093\/bjs\/znad228","volume":"110","author":"RAG van Eerden","year":"2023","unstructured":"van Eerden RAG, de Boer NL, van Kooten JP, et al. Phase I study of intraperitoneal irinotecan combined with palliative systemic chemotherapy in patients with colorectal peritoneal metastases. BJS. 2023;110(11):1502\u201310. https:\/\/doi.org\/10.1093\/bjs\/znad228.","journal-title":"BJS."},{"issue":"8","key":"18903_CR45","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1002\/jso.25920","volume":"121","author":"MR Woeste","year":"2020","unstructured":"Woeste MR, Philips P, Egger ME, Scoggins CR, McMasters KM, Martin RCG. Optimal perfusion chemotherapy: A prospective comparison of mitomycin C and oxaliplatin for hyperthermic intraperitoneal chemotherapy in metastatic colon cancer. J Surg Oncol. 2020;121(8):1298\u2013305. https:\/\/doi.org\/10.1002\/jso.25920.","journal-title":"J Surg Oncol."},{"issue":"5","key":"18903_CR46","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.7150\/thno.69424","volume":"12","author":"C Zhang","year":"2022","unstructured":"Zhang C, Xu C, Gao X, Yao Q. Platinum-based drugs for cancer therapy and anti-tumor strategies. Theranostics. 2022;12(5):2115\u201332. https:\/\/doi.org\/10.7150\/thno.69424.","journal-title":"Theranostics."},{"issue":"1","key":"18903_CR47","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1158\/1535-7163.MCT-08-0840","volume":"8","author":"SR McWhinney","year":"2009","unstructured":"McWhinney SR, Goldberg RM, McLeod HL. Platinum Neurotoxicity Pharmacogenetics. Mol Cancer Ther. 2009;8(1):10\u20136. https:\/\/doi.org\/10.1158\/1535-7163.MCT-08-0840.","journal-title":"Mol Cancer Ther."},{"key":"18903_CR48","unstructured":"Platinum-based chemotherapy: What to know. August 30, 2023. Accessed September 25, 2025. https:\/\/www.medicalnewstoday.com\/articles\/platinum-based-chemotherapy"},{"issue":"28","key":"18903_CR49","doi-asserted-by":"publisher","first-page":"3799","DOI":"10.3748\/wjg.v13.i28.3799","volume":"13","author":"S Kosmider","year":"2007","unstructured":"Kosmider S, Lipton L. Adjuvant therapies for colorectal cancer. World J Gastroenterol WJG. 2007;13(28):3799\u2013805. https:\/\/doi.org\/10.3748\/wjg.v13.i28.3799.","journal-title":"World J Gastroenterol WJG."},{"issue":"5","key":"18903_CR50","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1053\/j.gastro.2008.02.098","volume":"134","author":"BM Wolpin","year":"2008","unstructured":"Wolpin BM, Mayer RJ. Systemic Treatment of Colorectal Cancer. Gastroenterology. 2008;134(5):1296\u2013310. https:\/\/doi.org\/10.1053\/j.gastro.2008.02.098.","journal-title":"Gastroenterology."},{"issue":"1","key":"18903_CR51","doi-asserted-by":"publisher","first-page":"e1919325","DOI":"10.1001\/jamanetworkopen.20199.19325","volume":"3","author":"PB Imrey","year":"2020","unstructured":"Imrey PB. Limitations of Meta-analyses of Studies With High Heterogeneity. JAMA Netw Open. 2020;3(1):e1919325. https:\/\/doi.org\/10.1001\/jamanetworkopen.20199.19325.","journal-title":"JAMA Netw Open."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18903-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18903-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18903-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T15:47:17Z","timestamp":1773330437000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18903-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,16]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["18903"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18903-4","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,16]]},"assertion":[{"value":"6 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}